Long noncoding RNAs and the genetics of cancer
By S. Cheetham, F. Gruhl, John S. Mattick, Marcel E. Dinger. British Journal of Cancer, 2013
752 citations recorded by the source corpus.
Cancer is a disease of aberrant gene expression. While the genetic causes of cancer have been intensively studied, it is becoming evident that a large proportion of cancer susceptibility cannot be attributed to variation in protein-coding sequences. This is highlighted by genome-wide association studies in cancer that reveal that more than 80% of cancer-associated SNPs occur in noncoding regions of the genome. In this review, we posit that a significant fraction of the genetic aetiology of cancer is exacted by noncoding regulatory sequences, particularly by long noncoding RNAs (lncRNAs). Recent studies indicate that several cancer risk loci are transcribed into lncRNAs and these transcripts play key roles in tumorigenesis. We discuss the epigenetic and other mechanisms through which lncRNAs function and how they contribute to each stage of cancer progression, understanding of which will be crucial for realising new opportunities in cancer diagnosis and treatment. Long noncoding RNAs play important roles in almost every aspect of cell biology from nuclear organisation and epigenetic regulation to post-transcriptional regulation and splicing, and we link these processes to the hallmarks and genetics of cancer. Finally, we highlight recent progress and future potential in the application of lncRNAs as therapeutic targets and diagnostic markers.
Subfields: Cancer Research, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/fff8890d7c7423312e74460478a73e544dbe8cb7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Molecular Biology
Citations in the corpus
- Long non-coding RNAs and complex diseases: from experimental results to computational models (2016, background): “Considering the various functions of lncRNAs, it is no surprise to find that the mutations and dysregulations of lncRNAs are closely related to the development and progression of many kinds of human diseases [2, 16, 69, 82, 97–99], such as breast cancer [21, 100], prostate cancer [22, 23], hepatocel”